Recent News

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Sep 12, 2018

News Scan for Sep 12, 2018

Nigeria assist for UK monkeypox
Measles and public health cuts
Global Fund disease progress
Seqirus cell-based flu vaccine
Sep 07, 2018
Capsules and syringe

Study provides data behind new MDR-TB guidance

Newer and repurposed drugs produced better results and fewer deaths than older treatments did.

Aug 28, 2018

News Scan for Aug 28, 2018

MERS vaccine partnership
Molecular TB testing
H5N1 avian flu in Malaysia
Aug 27, 2018

Stewardship / Resistance Scan for Aug 27, 2018

Bedaquiline for MDR-TB
Australian stewardship study
Aug 21, 2018

Stewardship / Resistance Scan for Aug 21, 2018

Antibiotics for kids' UTIs
Drug-resistant TB surveillance model
Aug 20, 2018
MDR-TB detection

WHO revises MDR-TB treatment with focus on oral drugs

The changes prioritize newer medications and oral regimens over injectable drugs.

Aug 02, 2018

News Scan for Aug 02, 2018

Ebola species in DRC
Gaps in school crisis plans
Rat lungworm infection
Longhorned tick in Pennsylvania
Latent TB treatment
Trump's science adviser
Jul 12, 2018

News Scan for Jul 12, 2018

US drug shortage task force
TB vaccine candidates
Fractional dosing for yellow fever
Influenza B in pigs
Avian flu outbreaks
Jul 12, 2018

Stewardship / Resistance Scan for Jul 12, 2018

Stewardship nudge
MDR-TB in kids
Mycoplasma genitalium guidelines

Resources & Literature

Recent Literature

Abubakar I, Drobnieswki F, Southern J, et al. Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. Lancet Infect Dis 2018 (published online Aug 30)

Ahmad N, Ahuja SD, Akkerman OW, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet 2018 Sep 8;392(10150):821-34

Anaraki S, Bell AJ, Perkins S, et al. Expected background rates of latent TB infection in London inner city schools: lessons from a TB contact investigation exercise in a secondary school. Epidemiol Infect 2018 (published online Aug 23)

Bastos ML, Cosme LB, Fregona G, et al. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis. BMC Infect Dis 2017 Nov 14;17:718

Bei C, Fu M, Zhang Y, et al. Mortality and associated factors of patients with extensive drug-resistant tuberculosis: an emerging public health crisis in China. BMC Infect Dis 2018 Jun 7;18:261

Belard S, Heller T, Orie V, et al. Sonographic findings of abdominal tuberculosis in children with pulmonary tuberculosis. Pediatr Infect Dis J 2017 Dec 35(12):1224-6

Belknap R, Holland D, Feng PJ, et al. Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial. Ann Intern Med 2017 (published online Nov 7)

Brent AJ, Nyundo C, Langat J, et al. Prospective observational study of incidence and preventable burden of childhood tuberculosis, Kenya. Emerg Infect Dis 2018 (published online Jan 29)

Chernyaeva E, Rotkevich M, Krasheninnikova K, et al. Whole-genome analysis of Mycobacterium tuberculosis from patients with tuberculous spondylitis, Russia. Emerg Infect Dis 2018 (published online Jan 29)

Conlangeli R, Jedrey H, Kim S, et al. Bacterial factors that predict relapse after tuberculosis therapy. N Engl J Med 2018 Aug 30;379(9):823-33

Cruz AT, Starke JR. Completion rate and safety of tuberculosis infection treatment with shorter regimens. Pediatrics 2018 (published online Jan 23)

Davidson JA, Thomas HL, Maguire H, et al. Understanding TB transmission in the UK: findings from six years of MIRU-VNTR strain typing, 2010 to 2015. Am J Epidemiol 2018 (published online Jun 7)

Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health 2018 Apr 2;18:422

Diallo T, Adjobimey M, Ruslami R, et al. Safety and side effects of rifampin versus isoniazid in children. N Engl J Med 2018 Aug 2;379(5):454-63

Dobler CC, Farah WH, Alsawas M, et al. Tuberculin skin test conversions and occupational exposure risk in US healthcare workers. Clin Infect Dis 2017 (published online Oct 4)

Duque-Silva A, Hampole V, Cheng YN, et al. Outcomes of pediatric central nervous system tuberculosis in California, 1993-2011. J Pediatr Infect Dis Soc 2018 (published online Sep 4)

Faust L, McCarthy A, Schreiber Y. Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries. BMC Public Health 2018 Aug 6;18:979

Ferlazzo G, Mohr E, Laxmeshwar C, et al. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Lancet Infect Dis 2018 (published online Feb 13)

Fox GJ, Nguyen VN, Dinh NS, et al. Post-treatment mortality among patients with tuberculosis: a prospective cohort study of 10,964 patients in Vietnam. Clin Infect Dis 2018 (published online Sep 7)

Garfein RS, Liu L, Cuevas-Mota J, et al. Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA. Emerg Infect Dis 2018 (published online Aug 30)

Getnet F, Sileshi H, Seifu W, et al. Do retreatment tuberculosis patients need special treatment response follow-up beyond the standard regimen? Finding of five-year retrospective study in pastoralist setting. BMC Infect Dis 2017 Dec 12;17:762

Goyal V, Kadam V, Narang P, et al. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health 2017 Oct 17;17:817

Greenaway C, Pareek M, Chakra CNA, et al. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. Euro Surveill 2018 Apr 5;23(14):pii=17-00542

Guthrie JL, Kong C, Roth D, et al. Molecular epidemiology of tuberculosis in British Columbia, Canada — a 10-year retrospective study. Clin Infect Dis 2017 (published online Oct 21)

Haddad MB, Raz KM, Lash TL, et al. Simple estimates for local prevalence of latent tuberculosis infection, United States, 2011-2015. Emerg Infect Dis 2018 (published online Sep 5)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»